Work Productivity/Interference and General Health Status Improvements with Sirukumab, an Anti-Il-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Treatment with Disease-Modifying Anti-Rheumatic Drugs- Res ...
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1135
https://www.valueinhealthjournal.com/article/S1098-3015(16)32501-3/fulltext
Title :
Work Productivity/Interference and General Health Status Improvements with Sirukumab, an Anti-Il-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Treatment with Disease-Modifying Anti-Rheumatic Drugs- Res ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32501-3&doi=10.1016/j.jval.2016.09.1135
First page :
A542
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1064